For the second time this year, Lanx Inc., a Broomfield-based medical-device company, has named a new CEO from Minnesota.
This time it’s Dan Gladney, a med-tech veteran.
Gladney, whose appointment was announced this week, most recently served as healthcare operating partner at Norwest Equity Partners, a Minneapolis-based private-equity firm.
He was formerly CEO of Heart Leaflet Technologies, which was sold to Bracco Group earlier this year. In addition, he co-founded Acist Medical Systems (also sold to Bracco) and was chairman of Minnetonka, Minn.-based DGIMed Ortho.
Back in June, Lanx announced Michael DeMane, former COO of Medtronic Inc., was its new chairman and CEO, saying at the time that co-founder and former CEO Michael Fulton was becoming its chief technology officer.
But a few weeks later, the company said DeMane “declined to assume the role” and instead would “assist the company as a consultant.”
A Lanx official couldn’t be reached for comment.
Lanx focuses on developing and commercializing devices for spinal surgery.
Read more: Lanx names new CEO ― again | Denver Business Journal
